Just over a year ago, Dr. Lisandra Herrera Belén, an academic at the Universidad Santo Tomás Temuco, announced an innovative line of research in conjunction with the AU and UDD, aimed at identifying new sources of L-asparaginase, an enzyme used in the treatment of leukemia. Today, this work presents important advances that bring the team closer to one of its main objectives: to evaluate the therapeutic potential of microorganisms from Antarctica…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Just over a year ago, Dr. Lisandra Herrera Belén, an academic at the Universidad Santo Tomás Temuco, announced an innovative line of research in conjunction with the AU and UDD, aimed at identifying new sources of L-asparaginase, an enzyme used in the treatment of leukemia. Today, this work presents important advances that bring the team closer to one of its main objectives: to evaluate the therapeutic potential of microorganisms from Antarctica…